Stock Quote

Advanced Life Sciences Holdings, Inc. (ADLS.OB) (OTC BB)
As of  2 Dec 2009
0.22USD
Price Change
+0.01
Percent Change
+3.33%
 
$0.22
2 Dec 2009
+3.33%
$0.21
$0.21
690,220
$0.22
$0.21
$1.62
$0.14
3.44
435,024

Research Another Stock: Symbol Look-up
U.S. FDA advisory meetings through Aug 4
Friday, 29 May 2009 05:52pm EDT 
U.S. FDA advisory meetings through June 30
Friday, 22 May 2009 10:03am EDT 
U.S. FDA advisory meetings through June 30
Wednesday, 13 May 2009 11:44am EDT 
U.S. FDA advisory meetings through June 30
Tuesday, 5 May 2009 03:21pm EDT 
U.S. FDA advisory meetings through June 30
Tuesday, 5 May 2009 03:20pm EDT 
Healthcare Market Movers: SMMX, INSM, ADLS, HEB, ACUR and HALO
Wednesday, 24 Jun 2009 09:49am EDT(Seeking Alpha) 
Pending FDA Decisions: 20 Extreme Trades
Monday, 22 Jun 2009 05:08am EDT(Seeking Alpha) 
13 Extreme FDA Trades
Tuesday, 2 Jun 2009 03:38am EDT(Seeking Alpha) 
Pending FDA Decisions: 12 Extreme Trades
Wednesday, 20 May 2009 03:18am EDT(SeekingAlpha) 
Vanda Pharma: An Extreme FDA Trade That Paid; 9 More to Go
Thursday, 7 May 2009 05:19am EDT(SeekingAlpha) 
 
Name Current Position Compensation
Flavin, Michael Chairman of the Board, Chief Executive Officer 383,457
Flavin, John President, Chief Financial Officer, Secretary, Director 322,120
Xu, Ze-Qi Executive Vice President, Chief Scientific Officer 297,002

Profile

Advanced Life Sciences Holdings, Inc., is a biopharmaceutical company focused on the discovery, development and commercialization of drugs in the areas of infectious disease, oncology and respiratory disease. The Company has assembled a pipeline of clinical and preclinical product candidates. In... Full Description

Company Address

Advanced Life Sciences Holdings, Inc.
1440 Davey Road
Woodridge   IL   60517
P: +1630.7396744
F: +1630.7396754

Analyst Research

Performance of Key Competitors

Company Price Change
Sanofi-Aventis SA €52.79 +0.72
Pfizer Inc. $18.74 -0.11
GlaxoSmithKline plc £1,282.00 +2.00
  ADLS.OB Industry
P/E(TTM) -- 3.62
P/S(TTM) 9.15 0.56
ROI(TTM) -1,584.32 1.85
ROE(TTM) -- 2.49
No consensus estimates data available.
Total Revenue $0.71M
Net Income $-2.57M
EPS $-0.06